Guidance on air freight of medicines in a no-deal Brexit

Guidance on moving medicines by air as part of the contingency planning for no-deal Brexit



Stay up to date

The UK is leaving the EU. This page tells you how to prepare for Brexit and will be updated if anything changes.

Sign up for email alerts to get the latest information.

In a no-deal Brexit, supply chains for products sourced from the European Union and European Economic Area (EEA) may be affected by changes to border processes and procedures.

Pharmaceutical companies have been contingency planning to ensure continuity of supply. These measures include building stockpiles and using air freight to avoid any border delays.

The shipment of medicines by air freight requires specific control measures. This guidance provides advice on Good Distribution Practice (GDP) requirements for air freight to ensure that product quality and security is protected.

This guidance will apply from exit day in line with the Human Medicines Regulations (Amendment etc.) (EU Exit) Regulations 2019.

Published 11 March 2019
Last updated 9 October 2019 + show all updates
  1. Change of text within Stay up to date box.
  2. First published.